Rocket Pharmaceuticals
RCKT
RCKT
82 hedge funds and large institutions have $109M invested in Rocket Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
5% more funds holding
Funds holding: 78 → 82 (+4)
47% less capital invested
Capital invested by funds: $206M → $109M (-$97.5M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
82
Holding in Top 10
1
Calls
$6.46M
Puts
$4.77M
Top Buyers
| 1 | +$8.58M | |
| 2 | +$1.03M | |
| 3 | +$985K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$690K |
| 5 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$617K |
Top Sellers
| 1 | -$8.34M | |
| 2 | -$2.83M | |
| 3 | -$1.73M | |
| 4 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
-$1.71M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$1.61M |